SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000920465-16-000120
Filing Date
2016-07-22
Accepted
2016-07-22 16:48:46
Documents
4
Period of Report
2016-07-22
Effectiveness Date
2016-07-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy2016.htm DEF 14A 696647
2 GRAPHIC image1a01.jpg GRAPHIC 164429
3 GRAPHIC lajolla2016proxycard001.jpg GRAPHIC 185779
4 GRAPHIC lajolla2016proxycard002.jpg GRAPHIC 109323
  Complete submission text file 0000920465-16-000120.txt   1322624
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36282 | Film No.: 161780102
SIC: 2836 Biological Products, (No Diagnostic Substances)